Researchers have identified a previously unknown vulnerability in Plasmodium vivax, the most widespread malaria parasite outside sub-Saharan Africa. This parasite poses a major global health challenge because it can form dormant stages in liver cells, remaining hidden for months or years before reactivating to cause debilitating relapses. In fact, approximately three-quarters of Plasmodium vivax transmissions stem from these relapses rather than direct mosquito bites.
Scientists discovered that antibodies can target a specific region on the parasite’s circumsporozoite protein, which covers its surface. In laboratory experiments, targeting this vulnerable site successfully prevented the parasite from invading liver cells. Stopping the infection at this early stage prevents dormant forms from establishing themselves in the human body.
The breakthrough occurred when two independent teams from the University of South Florida converged on the same finding from different angles. One group examined human immune responses, while the other analyzed the molecular structure of the parasite. Combining their data provided compelling evidence for the potential of this target.
Although human trials and an approved vaccine remain several years away, researchers believe this work confirms feasibility. The next phase will focus on designing concrete vaccine formulations to control the disease.
Difficult words
- vulnerability — a weak point that can be attacked or harmedvulnerable
- dormant — temporarily inactive or resting for a period of time
- relapse — a return of a disease after a temporary improvementrelapses
- transmission — the process of passing something from one person or host to anothertransmissions
- feasibility — the possibility that something can be done successfully
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Why is stopping a parasite before it forms dormant stages in liver cells important for medical treatment?
- What are some of the main challenges researchers face when moving from laboratory experiments to human vaccine trials?
- How might international scientific collaboration speed up discoveries in global health?
Related articles
African leaders urged to fix health financing at UNGA80
At the 80th UN General Assembly in New York, Obinna Ebirim urges African countries to press for fairer donor partnerships and to increase domestic health funding. He highlights staff shortages, weak infrastructure and the National Health Fellows Programme.
Highly processed foods are almost always in binge eating
A review of research finds that highly processed foods appear in most binge-eating episodes, while minimally processed foods are rare. The authors say this pattern could change prevention and treatment and appears in a specialist journal.